The Effects of Aging and Estrogen on the Pituitary

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Healthy

In brief

The purpose of this study is to study the effects of aging and estrogen on the brain. Specifically, this study will examine how the hypothalamus signals the pituitary gland to secrete reproductive hormones and how that changes with aging.

Key facts

Study ID

NCT00386022

Run by

Massachusetts General Hospital

People needed

19

Starts

2002-01-01

Expected to finish

2018-01-01

Last updated by the study team

2017-04-13

Who can join

Age: 45 and older, up to 80. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 45-55 or 70-80 years old
• History of natural menopause defined by the absence of menses for at least 12 months (or history of surgical menopause defined as bilateral oophorectomy) and a FSH level >26 IU/L
• On no hormonal medication or herbal supplements and/or over the counter menopause therapy for a minimum of 2 months prior to study
• Normal thyroid stimulating hormone, prolactin, factor V Leiden, and complete blood count - Normal blood urea nitrogen and creatinine (< 2 times the upper limit of normal)
• basal metabolic index ≤ 30
• Non-smokers or smoke less than 10 cigarettes/day

You may not qualify if…

• Absolute contraindications to the use of physiologic replacement doses of estrogen, including a negative screening mammogram within the past 24 months
• History of coronary artery disease
• On medications thought to act centrally on the GnRH pulse generator
• Past history of hypersensitivity or allergy to narcotics, vancomycin, muscle relaxants, aspirin, and/or anaphylactic reaction(s) to other drugs
• Prior history of breast cancer and/or blood clots

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.